SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001493152-22-017138
Filing Date
2022-06-17
Accepted
2022-06-17 16:01:44
Documents
2
Period of Report
2022-06-16

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 1613
2 ex-24.htm EX-24 8873
  Complete submission text file 0001493152-22-017138.txt   12057
Mailing Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827
Business Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827 908-200-7500
Celldex Therapeutics, Inc. (Issuer) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address C/O MEDIVATION, INC. 201 SPEAR ST., 3RD FLOOR SAN FRANCISCO CA 94105
Business Address
Cohen Cheryl (Reporting) CIK: 0001529371 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-15006 | Film No.: 221023674